Jim Cramer says it's time to look beyond tech. Here are 4 consumer stocks he likes

The consumer staples index gained 11.4% in October, while the Nasdaq-100 fell almost 7%, as investors rotated toward defensive stocks amid technology-sector weakness. Jim Cramer recommended considering staples and highlighted Kimberly-Clark, Procter & Gamble, Constellation Brands and Coca-Cola, citing factors including Kimberly-Clark’s 4.7% dividend yield, Constellation’s 15% shipment growth in wine and spirits, and recent results at P&G and Coca-Cola. The article is primarily investment commentary, not a new company-wide catalyst.

Analysis

The key risk is buying defensive exposure after a sharp sector rerating: if tech stabilizes or real yields rise, staples’ relative-flow tailwind can reverse before company fundamentals change. The October move therefore supports selectivity, not a blanket staples overweight. Over the next 1–3 months, KO has the cleaner operating signal if volume growth holds; it is less dependent on extracting more price from consumers. By contrast, KMB’s apparent cheapness is not a standalone valuation case while the Kenvue transaction is pending: deal financing, integration costs, realized synergies and regulatory clearance will determine whether value accrues to KMB shareholders or is offset by execution and balance-sheet risk. KVUE could face a relative overhang if investors focus on the assets leaving, but deal terms and its post-transaction outlook are needed before taking that view. STZ’s shipment improvement is encouraging, but shipment growth alone does not establish a durable recovery in consumer demand or margins. Over 6–18 months, the test is whether volume and mix—not renewed price increases or one-off portfolio effects—support earnings. Contrarian point: defensive labels do not immunize these stocks from duration risk or crowded positioning; a reversal in rates or risk appetite could compress relative multiples despite stable sales.

Key Decisions for Investors

• Avoid chasing the sector’s one-month surge. Consider adding defensive exposure on relative-strength pullbacks, and reassess if staples begin losing relative performance as tech stabilizes or real yields rise.
• Prefer KO over a broad staples basket as a conditional quality expression: add only if subsequent results confirm volume-led growth. Falsifier: volume weakens and reported growth again depends chiefly on pricing.
• Treat KMB as a merger-event watch, not simply a low-multiple/high-yield buy. Before sizing, verify transaction terms, financing and expected synergies; reduce the thesis if clearance is delayed, costs rise, or integration guidance disappoints. Monitor KVUE for deal-related relative weakness, but do not short without clarity on consideration and its standalone outlook.
• Keep STZ on a confirmation watch rather than extrapolating shipment growth. Look for sustained beer share and improving wine-and-spirits economics; a reversal in shipment trends or weaker guidance would invalidate the turnaround case.